跳至主要内容
临床试验/JPRN-UMIN000037239
JPRN-UMIN000037239招募中未知

Evaluation of the efficacy of romosozumab for glucocorticoid-induced osteoporosis in initial glucocorticoid administration patients - Evaluation of the efficacy of romosozumab for glucocorticoid-induced osteoporosis in initial glucocorticoid administration patients

Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine0 个研究点目标入组 90 人开始时间: 2019年7月7日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who have received romosozumab or denosumab or bisphosphonate 2. Patients with contraindication for romosozumab or denosumab or bisphosphonate 3. Patients with severe renal dysfunction (eGFR < 30mL/min/1.73m2) 4. Patients who is currently pregnant, breastfeeding or willing to get pregnant 5. Patients who do not give consent to the study 6. Patients who are judged to be inappropriate by the physician

研究者

发起方
Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine

相似试验